Bill > HR4993

This bill aims to expand Medicare coverage for external infusion pumps and home infusion drugs that previously did not qualify for home use. Specifically, the bill allows Medicare to cover external infusion pumps and associated drugs that do not currently meet the standard "appropriate for use in home" requirement, provided three key criteria are met: (1) the drug's FDA-approved prescribing information requires administration by or under healthcare professional supervision, (2) a qualified home infusion therapy supplier administers or supervises the drug's administration safely in the patient's home, and (3) the drug is infused at least 12 times per year intravenously, subcutaneously, or at infusion rates determined by the Secretary of Health and Human Services to require an external pump. Additionally, the bill requires that patients be notified about the cost-sharing implications of choosing home infusion therapy compared to other care settings under Medicare. Named after Joe Fiandra, the bill seeks to improve patient access to home-based medical treatments by expanding Medicare's coverage of complex infusion therapies that previously might have been restricted to clinical settings.

Business and Industry

https://www.congress.gov/bill/119th-congress/house-bill/4993/all-info